Hunter Associates Investment Management’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
Hunter Associates Investment Management's BIIB Position: Q2 2026 in Review
Hunter Associates Investment Management reduced its Biogen (BIIB) stake by 1.3% in Q2 2026, selling an estimated $7.27K and leaving 2,901 shares worth $626K. The position accounts for 0.07% of the portfolio, ranked #183.
Hunter Associates Investment Management first reported a position in BIIB in Q2 2019 and has held it in 16 quarters since. 684 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.
- Hunter Associates Investment Management held 2,901 shares of Biogen worth $626K as of Q2 2026.
- Hunter Associates Investment Management sold 38 Biogen shares in Q2 2026, an estimated $7.27K.
- Biogen made up 0.07% of Hunter Associates Investment Management's portfolio in Q2 2026, its #183 holding.
- Hunter Associates Investment Management first reported a position in Biogen in Q2 2019 and has held it in 16 quarters since.
- 684 funds tracked by Wall St. Rank held Biogen as of Q2 2026.
Based on Hunter Associates Investment Management's 13F filing for Q2 2026, filed 23 Jul 2026.